Amgen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Amgen and other ETFs, options, and stocks.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

26,700

Employees26,700

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

26,700

Employees26,700

AMGN Key Statistics

Market cap

142.17B

Market cap142.17B

Price-Earnings ratio

33.87

Price-Earnings ratio33.87

Dividend yield

3.40%

Dividend yield3.40%

Average volume

4.67M

Average volume4.67M

High today

—

High today—

Low today

—

Low today—

Open price

$262.48

Open price$262.48

Volume

0.00

Volume0.00

52 Week high

$346.85

52 Week high$346.85

52 Week low

$253.30

52 Week low$253.30

AMGN News

TipRanks 2d

Is Amgen a High-Quality Dividend Stock on Sale?

My long-term investing strategy centers on buying high-quality businesses on sale and holding them for the long haul. Comprised of 30 of the best businesses in...

Benzinga 6d

What's Going On With Amgen Stock On Friday?

On Friday, Novo Nordisk A/S NVO released headline results from the REDEFINE 1 Phase 3 trial in the global REDEFINE program. When evaluating the effects of trea...

TipRanks 6d

Novo obesity data positive for Eli Lilly and Amgen, says UBS

UBS analyst Trung Huynh says Novo Nordisk’s (NVO) CagriSema Phase 3 topline obesity data “underwhelmed,” a positive read-through to Eli Lilly (LLY) and Amgen (A...

Analyst ratings

47%

of 34 ratings

Buy

44.1%

Hold

47.1%

Sell

8.8%